325
Participants
Start Date
December 31, 2012
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
EndoBarrier
Endoscopically-delivered and removable device comprised of an anchor that is placed in the duodenal bulb and a 60 cm long impermeable liner that passes distal from the anchor point
Sham Procedure
Endoscopic evaluation but no device placement
Beth Israel Medical Center, New York
MedStar Health Research Institute, Hyattsville
University of North Carolina, Chapel Hill
Emory University, Atlanta
University of Alabama at Birmingham, Birmingham
Endocrinology Consultants of East Tennessee & Gastrointestinal Associates, Knoxville
Kentucky Research Group, Louisville
Cleveland Clinic, Cleveland
University of Michigan, Ann Arbor
Mayo Clinic Minnesota, Rochester
Billings Clinic, Billings
Northwestern University, Chicago
Washington University, St Louis
Little Rock Diagnostic Center (LRDC), Little Rock
Dallas Diabetes, Dallas
The Methodist Hospital Research Institute, Houston
University of Colorado/ Anschutz Health & Wellness Center, Aurora
Mayo Clinic Arizona, Scottsdale
Cedars-Sinai Medical Center, Los Angeles
Stanford University School of Medicine, Stanford
Legacy Research Institute, Portland
Tulane University Health Sciences Center, New Orleans
Massachusetts General Hospital, Boston
Boston Medical Center, Boston
UT Southwestern Medical Center, Dallas
Lead Sponsor
Morphic Medical Inc.
INDUSTRY